loading page

Selective Immunoglobulin E Deficiency and Its Association with Autoimmune and Autoinflammatory Diseases: Findings from a 5-Year Single-Center Study
  • +5
  • Mehmet Emin Gerek,
  • Fatih Colkesen,
  • Tugba Onalan,
  • FATMA ARZU AKKUŞ,
  • Mehmet Kilinc,
  • Recep Evcen,
  • Selim Kahraman,
  • Sevket Arslan
Mehmet Emin Gerek
Necmettin Erbakan Universitesi Tip Fakultesi

Corresponding Author:[email protected]

Author Profile
Fatih Colkesen
Necmettin Erbakan Universitesi Tip Fakultesi
Author Profile
Tugba Onalan
Necmettin Erbakan Universitesi Tip Fakultesi
Author Profile
FATMA ARZU AKKUŞ
Necmettin Erbakan Universitesi Tip Fakultesi
Author Profile
Mehmet Kilinc
Batman Egitim ve Arastirma Hastanesi
Author Profile
Recep Evcen
TC Saglik Bakanligi Recep Tayyip Erdogan Universitesi Egitim ve Arastirma Hastanesi
Author Profile
Selim Kahraman
Necmettin Erbakan Universitesi Tip Fakultesi
Author Profile
Sevket Arslan
Necmettin Erbakan Universitesi Tip Fakultesi
Author Profile

Abstract

Background: Selective immunoglobulin E deficiency (sIgED) is a rare immunological condition characterized by low serum IgE levels while maintaining normal levels of other immunoglobulin classes. Despite its underrecognized nature, sIgED has been implicated in immune dysregulation, potentially predisposing individuals to autoimmune and autoinflammatory diseases. Objective: This study aims to investigate the association between sIgED and immune-mediated diseases, exploring its prevalence, clinical implications, and underlying mechanisms. Methods: A retrospective cohort study was conducted over five years at a tertiary university hospital. Among 3,692 patients, individuals with serum IgE ≤ 2.5 kU/L were classified as having sIgED. Autoimmune and autoinflammatory conditions were analyzed in relation to IgE levels. Statistical analyses were performed using SPSS version 22.0. Results: Autoimmune and autoinflammatory diseases were significantly more prevalent in the sIgED group than in controls (25.2% vs. 15.6%, p < 0.001). Specific associations were observed with Hashimoto’s thyroiditis, familial Mediterranean fever, and Behçet’s disease. Mechanistically, sIgED appears to impair mucosal immune barriers and immune regulation, potentially contributing to disease pathogenesis. Conclusion: sIgED is associated with a higher prevalence of autoimmune and autoinflammatory diseases, emphasizing its potential role as a biomarker for immune dysregulation. These findings highlight the need for routine IgE level assessment in patients with suspected immune-mediated conditions and call for further research to elucidate underlying mechanisms.